Prostate cancer is one of the most common cancers in men worldwide, and its incidence has increased even in the last few years.[1–3] Clinically, patients with prostate cancer initially respond effectively to androgen depletion therapy, which induces apoptosis of tumor cells.[4] However, androgen depletion therapy becomes ineffective in most patients after a period of time. In these hormone-refractory prostate cancer cases, tumors become metastatic and ...
